Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review

BACKGROUND: As the popularity of long-acting reversible contraception increases, so does the need for accurate data on method continuation in diverse clinical settings. We determined 2-year continuation rates for the levonorgestrel 52-mg intrauterine device, the copper T380A intra-uterine device, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanders, Jessica N., Turok, David K., Gawron, Lori M., Law, Amy, Wen, Lonnie, Lynen, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040817/
https://www.ncbi.nlm.nih.gov/pubmed/28188772
http://dx.doi.org/10.1016/j.ajog.2017.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040817/
https://www.ncbi.nlm.nih.gov/pubmed/28188772
http://dx.doi.org/10.1016/j.ajog.2017.02.003

Ejemplares similares